{"id":"doi:10.1186/s13195-024-01666-7","kind":"article","title":"evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease","authors":["Jeffrey L. Cummings","Alireza Atri","Howard Feldman","Oskar Hansson","Mary Sano","Filip Krag Knop","Peter Johannsen","Teresa León","Philip Scheltens"],"author_count":9,"year":2025,"published":"2025-01-08","venue":"Alzheimer s Research & Therapy","cited_by":165,"doi":"10.1186/s13195-024-01666-7","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1186/s13195-024-01666-7","archive_url":"https://space-kitty.com/papers/doi:10.1186/s13195-024-01666-7","updated":null,"pmid":"39780249","pmcid":null,"openalex_id":"W4406156729","pdf_url":"https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-024-01666-7","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}